The good news is that this is also the period where the body is actively adapting to the higher receptor stimulation
[44] The drug delays gastric emptying, which can lead to indigestion, belching, and rarely, gastroparesis or bowel obstruction
Together, these effects not only reflect improved nutrient availability but also point to a more functional erythropoietic process, likely supported by enhanced mitochondrial ATP production within hematopoietic progenitors 62
Presented for research literature review only Enebo LB et al
Competing interests DG received honoraria for speaking at meetings from Novartis, Sanofi, Eli Lilly and Company, AstraZeneca, and Novo Nordisk
Trends Endocrinol Metab (2017) 28:12130